University Of California, Davis

This study tested a combination of two drugs, lenalidomide and rituximab, in 30 adults with untreated slow-growing non-Hodgkin's lymphoma. Participants took lenalidomide daily for three weeks each month and received rituximab infusions weekly for four weeks. The goal was to see h…

This study tested the drug niraparib in men with high-risk prostate cancer that had not spread. The drug targets tumors with specific DNA repair problems. Only 11 men enrolled before the study was stopped early. The goal was to see if the drug could shrink or eliminate tumors bef…